ReviewPharmacoEconomics - open2021

High-Expenditure Disease in the EU-28: Does Drug Spend Correspond to Clinical and Economic Burden in Oncology, Autoimmune Disease and Diabetes?

Wolfgang Greiner et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.